Tessera Therapeutics
Lead Investors
Abu Dhabi Investment Authority
,
Alaska Permanent Fund
,
Altitude Life Science Ventures
,
Artis Ventures
,
Cormorant Asset Management
,
Hanwha Impact
,
Longevity Vision Fund
,
March Capital
,
SALT Fund
,
SoftBank
, and
T. Rowe Price
대륙
US
법인설립년도
2018
산업
Biotechnology
서비스 소개
Gene writing technology
순번
48
지역
Cambridge, MA
최근 투자규모(달러환율 적용)
$300M
최종 투자규모(달러환율적용)
$530M
투자 단계
Series C